Abera Bioscience AB has announced the decision by CEPI (Coalition for Epidemic Preparedness Innovations) to extend the ongoing project supporting the development of Abera’s BERA vaccine platform and the company’s influenza vaccine candidate. The project period has been extended until Dec. 31, 2026, with the budget unchanged.